Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-04-17
2009-12-08
Haddad, Maher M (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007240, C530S387100
Reexamination Certificate
active
07629128
ABSTRACT:
This invention relates to methods of measuring HIF expression and activity, as well as measuring inhibition of HIF following administration of an HIF inhibitor useful in treating HIF related diseases. The present invention further relates to methods of identifying individuals who will respond to HIF inhibitors. The invention also relates to methods of monitoring a patient response to a given dosage of an HIF inhibitor. The invention also includes assays and kits for performing the methods described herein.
REFERENCES:
patent: 5602278 (1997-02-01), Kirkpatrick
Vordermark et al. Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies. Int J Radiat Oncol Biol Phys. Jul. 15, 2003;56(4):1184-93.
Makino et al. Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells. J Immunol. Dec. 15, 2003;171(12):6534-40.
Lim et al. Ras-dependent induction of HIF-1alpha785 via the Raf/MEK/ERK pathway: a novel mechanism of Ras-mediated tumor promotion. Oncogene. Dec. 16, 2004;23(58):9427-31.
Carraro et al. p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells. J Cell Physiol. May 2007;211(2):439-47.
Lukashev et al. Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes. J Biol Chem. Dec. 28, 2001;276(52):48754-63.
Mendis et al. Transcriptional response signature of human lymphoid cells to staphylococcal enterotoxin B. Genes Immun. Mar. 2005;6(2):84-94.
Zhou et al. NO and TNF-alpha released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells. Am J Physiol Cell Physiol. Feb. 2003;284(2):C439-46.
Powis, et al., Hypoxic inducible factor-1α as a cancer drug test, 2004, Mol. Cancer Ther. 3(5):647-654.
Welsh et al., PX-478—A Potent Inhibitor of Hypoxia-Inducible Factor-1 and Anti-Tumor Agent, Nov. 19-22, 2002, AACR-EORTC-NCI Meeting, Frankfurt, Germany.
Zalgeviciene et al., Embryotoxicity and teratogenicity of some derivatives of chloroethylaminophenylacetic acid, Pathology Onc. Res. 4(1):27-29, 1998.
Breivis et al., Faranoxi—A new antitumor agent, J. of Chemo. 8(1):67-69, 1996.
Kirkpatrick et al., Synthesis and bioreductive potential of a mono N-oxide derivative of the alkylating agent chlorambucil, 1994, Anti-Cancer Drugs 5:467-472.
Kirkpatrick Lynn
Pestano Linda Anne
Haddad Maher M
Pepper Hamilton LLP
Prolx Pharmaceuticals Corp.
LandOfFree
Methods of identifying respondents to hypoxia inducible... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of identifying respondents to hypoxia inducible..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying respondents to hypoxia inducible... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4149203